413 related articles for article (PubMed ID: 19513635)
21. Local delivery of cytokines by retrovirally transduced antigen-specific TCR+ hybridoma cells in experimental autoimmune encephalomyelitis.
Dal Canto RA; Costa G; Shaw MD; Seroogy C; Nolan GP; Fathman CG
Eur Cytokine Netw; 1998 Sep; 9(3 Suppl):83-91. PubMed ID: 9831193
[TBL] [Abstract][Full Text] [Related]
22. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
Martin R; McFarland HF
Crit Rev Clin Lab Sci; 1995; 32(2):121-82. PubMed ID: 7598789
[TBL] [Abstract][Full Text] [Related]
23. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.
Prinz M; Schmidt H; Mildner A; Knobeloch KP; Hanisch UK; Raasch J; Merkler D; Detje C; Gutcher I; Mages J; Lang R; Martin R; Gold R; Becher B; Brück W; Kalinke U
Immunity; 2008 May; 28(5):675-86. PubMed ID: 18424188
[TBL] [Abstract][Full Text] [Related]
24. Multiple sclerosis: a complicated picture of autoimmunity.
McFarland HF; Martin R
Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
[TBL] [Abstract][Full Text] [Related]
25. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
Holmøy T
Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
[TBL] [Abstract][Full Text] [Related]
26. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
Ziemssen T; Ziemssen F
Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
[TBL] [Abstract][Full Text] [Related]
27. Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice.
Peron JP; Yang K; Chen ML; Brandao WN; Basso AS; Commodaro AG; Weiner HL; Rizzo LV
J Neuroimmunol; 2010 Oct; 227(1-2):10-7. PubMed ID: 20580440
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis.
Jadidi-Niaragh F; Mirshafiey A
Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):545-67. PubMed ID: 21284556
[TBL] [Abstract][Full Text] [Related]
29. TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3+ Treg cells.
Lalive PH; Benkhoucha M; Tran NL; Kreutzfeldt M; Merkler D; Santiago-Raber ML
Eur J Immunol; 2014 Jan; 44(1):46-57. PubMed ID: 24018482
[TBL] [Abstract][Full Text] [Related]
30. Experimental autoimmune encephalomyelitis--achievements and prospective advances.
Batoulis H; Recks MS; Addicks K; Kuerten S
APMIS; 2011 Dec; 119(12):819-30. PubMed ID: 22085358
[TBL] [Abstract][Full Text] [Related]
31. The immune pathogenesis of experimental autoimmune encephalomyelitis: lessons learned for multiple sclerosis?
Kuerten S; Lehmann PV
J Interferon Cytokine Res; 2011 Dec; 31(12):907-16. PubMed ID: 21936633
[TBL] [Abstract][Full Text] [Related]
32. Cytokines and effector T cell subsets causing autoimmune CNS disease.
Petermann F; Korn T
FEBS Lett; 2011 Dec; 585(23):3747-57. PubMed ID: 21477588
[TBL] [Abstract][Full Text] [Related]
33. Deleterious versus protective autoimmunity in multiple sclerosis.
Kostic M; Stojanovic I; Marjanovic G; Zivkovic N; Cvetanovic A
Cell Immunol; 2015 Aug; 296(2):122-32. PubMed ID: 25944389
[TBL] [Abstract][Full Text] [Related]
34. [The significance of a B cell-dependent immunopathology in multiple sclerosis].
Kuerten S; Pauly R; Blaschke S; Rottlaender A; Kaiser CC; Schroeter M; Fink GR; Addicks K
Fortschr Neurol Psychiatr; 2011 Feb; 79(2):83-91. PubMed ID: 21253995
[TBL] [Abstract][Full Text] [Related]
35. New lessons about old molecules: how type I interferons shape Th1/Th17-mediated autoimmunity in the CNS.
Prinz M; Kalinke U
Trends Mol Med; 2010 Aug; 16(8):379-86. PubMed ID: 20591737
[TBL] [Abstract][Full Text] [Related]
36. Cell-based modulation of autoimmune responses in multiple sclerosis and experimental autoimmmune encephalomyelitis: therapeutic implications.
Mastorodemos V; Ioannou M; Verginis P
Neuroimmunomodulation; 2015; 22(3):181-95. PubMed ID: 24852748
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic benefits of regulating inflammation in autoimmunity.
Nikoopour E; Schwartz JA; Singh B
Inflamm Allergy Drug Targets; 2008 Sep; 7(3):203-10. PubMed ID: 18782028
[TBL] [Abstract][Full Text] [Related]
38. [Role of T-regulatory cells in multiple sclerosis].
Rojas JI; González SJ; Patrucco L; Cristiano E
Medicina (B Aires); 2010; 70(1):79-86. PubMed ID: 20228030
[TBL] [Abstract][Full Text] [Related]
39. Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis.
Lunin SM; Glushkova OV; Khrenov MO; Novoselova TV; Parfenyuk SB; Fesenko EE; Novoselova EG
Immunobiology; 2013 Mar; 218(3):402-7. PubMed ID: 22727332
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-17A and interleukin-17F mRNA expression in peripheral blood mononuclear cells of patients with multiple sclerosis.
Babaloo Z; Babaie F; Farhoodi M; Aliparasti MR; Baradaran B; Almasi S; Hoseini A
Iran J Immunol; 2010 Dec; 7(4):202-9. PubMed ID: 21189442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
